top of page
Man is analyzing AEYE-DS software in use on a computer presenting the fundus images analyzed with the diabetic retinopathy diagnostic result

AEYE Diagnostic Screening (AEYE-DS)

Autonomous Screening for
Diabetic Retinopathy (DR)

The first practical point-of-care screening solution for diabetic retinopathy

AEYE-DS software in use on a computer presenting the fundus images analyzed with the diabetic retinopathy diagnostic result

Benefits of Point-of-Care Screening

Vector Art of hand is positioned beneath the eye vector icon symbolizing care and support and representing practical

Practical

Requires only one image per eye; rarely requires dilation

Vector Art of Target Icon representing best in accuracy

Accurate

Best-in-class efficacy proven in a pivotal prospective FDA study

Vector Art of Male and Female Doctors  standing together representing simple to operate

Simple to operate

Screening, taking only two minutes for most patients, can be done by any healthcare staff

vector art of reimbursable report

Reimbursable

Dedicated CPT code 92229

Vector Art of AEYE Health Care - An image has two vector hands catching the heart representing closes care gaps

Closes Care Gaps

Closes the diabetic eye exam care gap for HEDIS/Star quality measures

How it works

Vector Art of Diagnostic Result Report
A vector image depicting an eye doctor conducting a check-up. The doctor is sitting on a chair  and using a magnifying lens to examine a patient's eye.
Vector Art of AEYE Health Image Analyzed by AI

3

2

1

Image

A single image per eye is obtained using an indicated camera

Analyze

Images are analyzed by the AI

Result

Diagnostic result returned in under a minute

Compatible Retinal Cameras

Topcon AEYE

Topcon NW fundus camera with the AEYE System - AEYE with Topcon NW-400
FDA Cleared Circle Logo in Blue
Component 152.png
Component 152.png
Component 152.png

Robotic camera automatically captures images

AI diagnosis within 2 minutes for most patients

No lock-in contracts

Regulatory Approval

On November 2022, the FDA cleared the use of AEYE-DS for the detection of more-than-mild diabetic retinopathy with the Topcon NW400 camera

Indications for Use

The AEYE-DS is indicated for use by health care providers to automatically detect-more-than-mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy.

Accuracy & Usability

In an FDA clinical study for the detection of more-than-mild diabetic retinopathy, the AEYE-DS was found to have 93% sensitivity and over 91.4% specificity using one image per eye captured using the Topcon NW400.

Aurora AEYE

Cost-effective, compact fundus camera with built-in diagnostic screening intelligence

Aurora AEYE Portable Fundus Camera Microclear Luna 16 mpx
Component 152.png
Component 152.png
Component 152.png

Compact, cost-effective retinal camera with built-in diagnostic screening intelligence

 

Aurora AEYE is the first portable camera capable of screening for diabetic retinopathy

 

Ease of use combined with accurate AI make it the first practical screening solution for primary caregivers

NOT SOLD IN THE US

CAUTION: Federal (US) law restricts this device to investigational use only.
 

See it in Action
Schedule a Demo
Autonomous Diagnostic Screening Specialist | AEYE Health

Have questions?
Ready to get started?

Thanks for submitting!

bottom of page